SCHEMBL12338211

SCHEMBL12338211

c1ccc(-n2c3ccccc3c3cc(-c4c5ccccc5c(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)c5c4ccc4ccccc45)ccc32)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ PTGES O14684 1/20 0.39
▸ PTGER4 P35408 1/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ NQO2 P16083 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ TSHR P16473 2/20 0.33
▸ IL1R1 P14778 1/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ SIGMAR1 Q99720 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ JAK2 O60674 1/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ BRCA1 P38398 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26813184 0.97 L3MBTL1 (0.46) L3MBTL1KDM4EATMPTGESPTGER4
SCHEMBL19103077 0.96 L3MBTL1 (0.45) L3MBTL1KDM4EATMPTGESPTGER4
SCHEMBL12338250 0.96 L3MBTL1 (0.45) L3MBTL1KDM4EATMPTGESPTGER4
SCHEMBL17718059 0.95 L3MBTL1 (0.44) L3MBTL1KDM4EATMPTGESPTGER4
SCHEMBL26813189 0.94 L3MBTL1 (0.43) L3MBTL1KDM4EATMPTGESPTGER4
SCHEMBL17718061 0.94 L3MBTL1 (0.43) L3MBTL1KDM4EATMPTGESPTGER4
SCHEMBL17718070 0.92 L3MBTL1 (0.39) L3MBTL1KDM4EATMPTGESPTGER4
SCHEMBL26813185 0.92 L3MBTL1 (0.46) L3MBTL1KDM4EATMPTGESPTGER4
SCHEMBL12338304 0.92 KDM4E (0.41) L3MBTL1KDM4EATMPTGESPTGER4
SCHEMBL12338273 0.92 KDM4E (0.41) L3MBTL1KDM4EATMPTGESPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8268459-B2 Benzanthracene compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2012-09-18 — — US disclosed
US-8268459-B2 Benzanthracene compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2012-09-18 — — US disclosed
US-20100301313-A1 BENZANTHRACENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. 2010-12-02 — — US disclosed
US-20100301313-A1 BENZANTHRACENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. 2010-12-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100301313-A1 BENZANTHRACENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME AHR, TRPA1, LEF1 L3MBTL1 3059/4885KDM4E 2280/4885ATM 1893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback